Oscar Health, Inc. $OSCR Shares Acquired by Fortis Group Advisors LLC

Fortis Group Advisors LLC increased its position in Oscar Health, Inc. (NYSE:OSCR) by 82.9% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 189,857 shares of the company’s stock after acquiring an additional 86,035 shares during the period. Fortis Group Advisors LLC’s holdings in Oscar Health were worth $2,724,000 at the end of the most recent reporting period.

Other large investors have also modified their holdings of the company. Handelsbanken Fonder AB increased its stake in Oscar Health by 5.2% during the 4th quarter. Handelsbanken Fonder AB now owns 40,400 shares of the company’s stock valued at $581,000 after buying an additional 2,000 shares during the period. Csenge Advisory Group acquired a new position in Oscar Health during the 4th quarter valued at about $428,000. ProShare Advisors LLC increased its stake in Oscar Health by 8.7% during the 4th quarter. ProShare Advisors LLC now owns 36,108 shares of the company’s stock valued at $519,000 after buying an additional 2,903 shares during the period. Halter Ferguson Financial Inc. increased its stake in Oscar Health by 1.1% during the 4th quarter. Halter Ferguson Financial Inc. now owns 389,397 shares of the company’s stock valued at $5,596,000 after buying an additional 4,082 shares during the period. Finally, Mitsubishi UFJ Asset Management Co. Ltd. acquired a new position in Oscar Health during the 4th quarter valued at about $260,000. Institutional investors and hedge funds own 75.70% of the company’s stock.

Insider Activity

In other Oscar Health news, CEO Mark T. Bertolini acquired 1,000,000 shares of Oscar Health stock in a transaction dated Monday, April 6th. The stock was bought at an average price of $11.92 per share, for a total transaction of $11,920,000.00. Following the transaction, the chief executive officer owned 10,196,876 shares in the company, valued at approximately $121,546,761.92. This trade represents a 10.87% increase in their position. The acquisition was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CFO Richard Scott Blackley sold 100,000 shares of the firm’s stock in a transaction dated Thursday, May 14th. The shares were sold at an average price of $23.16, for a total transaction of $2,316,000.00. Following the transaction, the chief financial officer owned 1,216,660 shares of the company’s stock, valued at approximately $28,177,845.60. This trade represents a 7.59% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Company insiders own 24.39% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities analysts have commented on the stock. Barclays raised their target price on shares of Oscar Health from $18.00 to $21.00 and gave the company an “equal weight” rating in a research note on Thursday, May 7th. UBS Group raised their target price on shares of Oscar Health from $15.00 to $20.00 and gave the company a “neutral” rating in a research note on Thursday, May 7th. Raymond James Financial raised shares of Oscar Health from a “market perform” rating to an “outperform” rating and set a $18.00 target price on the stock in a research note on Thursday, February 12th. Wall Street Zen raised shares of Oscar Health from a “hold” rating to a “strong-buy” rating in a research note on Saturday, May 9th. Finally, Jefferies Financial Group raised shares of Oscar Health from an “underperform” rating to a “hold” rating and raised their target price for the company from $10.00 to $16.00 in a research note on Monday, April 20th. One equities research analyst has rated the stock with a Strong Buy rating, two have assigned a Buy rating, seven have given a Hold rating and two have given a Sell rating to the company’s stock. According to data from MarketBeat, Oscar Health currently has an average rating of “Hold” and an average price target of $18.22.

Oscar Health Stock Performance

NYSE:OSCR opened at $23.40 on Thursday. Oscar Health, Inc. has a twelve month low of $10.69 and a twelve month high of $25.58. The company has a current ratio of 1.11, a quick ratio of 1.11 and a debt-to-equity ratio of 0.26. The company has a 50-day moving average of $16.13 and a 200-day moving average of $15.52. The firm has a market cap of $7.05 billion, a price-to-earnings ratio of -39.66, a price-to-earnings-growth ratio of 1.71 and a beta of 2.34.

Oscar Health (NYSE:OSCR) last posted its quarterly earnings data on Wednesday, May 6th. The company reported $2.07 earnings per share for the quarter, beating the consensus estimate of $1.11 by $0.96. Oscar Health had a negative net margin of 0.30% and a negative return on equity of 3.26%. The company had revenue of $4.65 billion during the quarter, compared to analyst estimates of $4.90 billion. During the same quarter last year, the firm posted $0.92 EPS. The business’s revenue for the quarter was up 52.6% on a year-over-year basis. Analysts forecast that Oscar Health, Inc. will post 0.47 earnings per share for the current fiscal year.

Oscar Health Company Profile

Oscar Health, trading on the New York Stock Exchange under the ticker OSCR, is a technology-driven health insurance company headquartered in New York, New York. Founded in 2012 by Mario Schlosser, Joshua Kushner and Kevin Nazemi, the company was built with the goal of simplifying healthcare coverage and enhancing member experience. Oscar leverages a proprietary digital platform to streamline plan enrollment, claims administration and member support, distinguishing itself in the individual, family and small group insurance markets.

The company’s primary products include on-exchange individual and family medical plans under the Affordable Care Act, off-exchange plans, as well as Medicare Advantage offerings.